{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["70(3)"],"submitter":["Campobasso D"],"journal":["Central European journal of urology"],"pagination":["324-325"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5656377"],"repository":["biostudies-literature"],"pubmed_title":["Very high-risk prostate cancer: multimodality treatment will be the new frontier."],"pmcid":["PMC5656377"],"pubmed_authors":["Frattini A","Prati G","Campobasso D"],"additional_accession":[]},"is_claimable":false,"name":"Very high-risk prostate cancer: multimodality treatment will be the new frontier.","description":null,"dates":{"release":"2017-01-01T00:00:00Z","publication":"2017","modification":"2025-04-18T19:46:39.42Z","creation":"2025-02-19T04:27:32.007Z"},"accession":"S-EPMC5656377","cross_references":{"pubmed":["29104799"],"doi":["10.5173/ceju.2017.1535"]}}